Yu L, Li W, Xu N, Liu X, et al. Patient-reported outcomes in adults with tyrosine kinase inhibitor-resistant chronic myeloid leukemia receiving olverembatinib therapy. Cancer 2024 Nov 26. doi: 10.1002/cncr.35652.
PMID: 39589859